{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23534926",
  "DateCompleted": {
    "Year": "2015",
    "Month": "03",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "01",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "03",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1186/bcr3397"
    ],
    "Journal": {
      "ISSN": "1465-542X",
      "JournalIssue": {
        "Volume": "15",
        "Issue": "2",
        "PubDate": {
          "Year": "2013",
          "Month": "Mar",
          "Day": "27"
        }
      },
      "Title": "Breast cancer research : BCR",
      "ISOAbbreviation": "Breast Cancer Res"
    },
    "ArticleTitle": "Elf5 - breast cancer's little helper.",
    "Pagination": {
      "StartPage": "307",
      "MedlinePgn": "307"
    },
    "Abstract": {
      "AbstractText": [
        "A variety of transcription factors has been shown to regulate lineage commitment in the mammary gland and to be associated with different molecular subtypes of breast cancer. E74-like factor 5 (Elf5) has now been identified as a marker of oestrogen receptor status, and high expression correlates with more aggressive basal cancers and resistance to anti-oestrogens. Manipulation of Elf5 transcript levels perturbs the molecular profiles of luminal and basal subtypes, highlighting the possibility that targeting Elf5 could provide a new approach for the treatment of basal cancers."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Frend",
        "ForeName": "Hayley T",
        "Initials": "HT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Watson",
        "ForeName": "Christine J",
        "Initials": "CJ"
      }
    ],
    "GrantList": [
      {
        "GrantID": "MR/K011014/1",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      },
      {
        "Acronym": "WT_",
        "Agency": "Wellcome Trust",
        "Country": "United Kingdom"
      },
      {
        "Acronym": "BB_",
        "Agency": "Biotechnology and Biological Sciences Research Council",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Breast Cancer Res",
    "NlmUniqueID": "100927353",
    "ISSNLinking": "1465-5411"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "DNA-Binding Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "ELF5 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Elf5 protein, mouse"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Proto-Oncogene Proteins c-ets"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Transcription Factors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "classification",
        "drug therapy",
        "metabolism"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "metabolism"
      ],
      "DescriptorName": "DNA-Binding Proteins"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Drug Resistance, Neoplasm"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "metabolism"
      ],
      "DescriptorName": "Proto-Oncogene Proteins c-ets"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "metabolism"
      ],
      "DescriptorName": "Transcription Factors"
    }
  ]
}